Have a personal or library account? Click to login
Severe COVID-19: How are these patients today Cover

References

  1. World Health Organization. WHO coronavirus dashboard. 2024. Available from: https://covid19.who.int/. [Accessed 20th September 2024].
  2. Antoniou KM, Vasarmidi E, Russell A, Andrejak C, Crestani B, Wells AU, et al. European Respiratory Society statement on long COVID-19 follow-up. Eur Respir J. Published online 2022. doi:10.1183/13993003.02174-2021.
  3. Madi W, Majdoub Fehri S, Ketata I, Eleuch AD, Ammar R, Sallami R, et al. Respiratory function in patients post-infection by COVID-19. European Respiratory Journal. 2022;60(Suppl 66): 1879. doi:10.1183/13993003.congress-2022.1879
  4. Greenhalgh T, Knight M, A’Court C, Buxton M, Husain L. Management of post-acute COVID-19 in primary care. BMJ. 2020;370: m3026. doi:10.1136/bmj.m3026
  5. Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. Post-acute COVID-19 syndrome. Natural Medicines. 2021;27: 601–615. doi:10.1038/s41591-021-01283-z
  6. COVID-19 rapid guideline: managing the long-term effects of COVID-19. NICE. 2021. Available from: http://www.nice.org.uk/guidance/ng188 [Accessed 2023].
  7. Mandal S, Barnett J, Brill SE, Brown JS, Denneny EK, Hare SS, et al. ‘Long-COVID’: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. 2021;76: 396–398. doi:10.1136/thoraxjnl-2020-215818
  8. Augustin M, Schommers P, Stecher M, Dewald F, Gieselmann L, Gruell H, et al. Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. The Lancet Regional Health. Europe. 2021;6: 1–8. doi:10.1016/j.lanepe.2021.100122
  9. George PM, Barratt SL, Condliffe R, Desai SR, Devaraj A, Forrest I, et al. Respiratory follow-up of patients with COVID-19 pneumonia. Thorax. 2020;75: 1009–1016. doi:10.1136/thoraxjnl-2020-215314
  10. National Institutes of Health. COVID-19 treatment guidelines panel. Coronavirus Disease 2019 (COVID-19). 2024. Available from: https://www.accp.com/report/index.aspx?art=3428&utm_source. [Accessed 20th December 2023].
  11. Fletcher CM, Elmes P, Fairbairn A, Wood C. The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. British Medical Journal. 1959;29: 257–266. doi:10.1136/bmj.2.5147.257
  12. Klok FA, Boon GJAM, Barco S, Endres M, Geelhoed JJM, Knauss S, et al. The post-COVID-19 functional status scale: a tool to measure functional status over time after COVID-19. European Respiratory Journal. 2020;56: 10–12. doi:10.1183/13993003.01494-2020
  13. Bellan M, Soddu D, Balbo PE, Baricich A, Zeppegno P, Avanzi GC, et al. Respiratory and psychophysical sequelae among patients with COVID-19 four months after hospital discharge. JAMA Network Open. 2021;4: 1–12. doi:10.1001/jamanetworkopen.2020.36142
  14. Lerum TV, Aaløkken TM, Brønstad E, Aarli B, Ikdahl E, Lund KMA, et al. Dyspnoea, lung function and CT findings 3 months after hospital admission for COVID-19. European Respiratory Journal. 2021;57: 2003448. doi:10.1183/13993003.03448-2020
  15. Gamberini L, Mazzoli CA, Prediletto I, Sintonen H, Scaramuzzo G, Allegri D, et al. Health-related quality of life profiles, trajectories, persistent symptoms and pulmonary function one year after ICU discharge in invasively ventilated COVID-19 patients: a prospective follow-up study. Respiratory Medicine. 2021;189: 106665. doi:10.1016/j.rmed.2021.106665
  16. Ribeiro Carvalho CR, Lamas CA, Chate RC, Salge JM, Sawamura MVY, de Albuquerque ALP, et al. Long-term respiratory follow-up of ICU hospitalized COVID-19 patients: prospective cohort study. Plos One. 2023;18: 1–16. doi:10.1371/journal.pone.0280567
  17. Zangrillo A, Belletti A, Palumbo D, Calvi MR, Guzzo F, Fominskiy EV, et al. One-year multidisciplinary follow-up of patients with COVID-19 requiring invasive mechanical ventilation. Journal of Cardiothoracic and Vascular Anesthesia. 2020;36(5): 1354–1363. doi:10.1053/j.jvca.2021.11.032
  18. Bellan M, Baricich A, Patrucco F, Zeppegno P, Gramaglia C, Balbo PE, et al. Long-term sequelae are highly prevalent one year after hospitalization for severe COVID-19. Scientific Reports. 2021;11: 1–10. doi:10.1038/s41598-021-01215-4
  19. Prestes GDS, Simon CS, Walz R, Ritter C, Dal-Pizzol F. Respiratory outcomes after COVID-19. Frontiers in Medicine. 2022;19: 1–7. doi:10.3389/fmed.2022.795074
  20. Wu X, Liu X, Zhou Y, Yu H, Li R, Zhan Q, et al. 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study. The Lancet Respiratory Medicine. 2021;9: 747–754. doi:10.1016/S2213-2600(21)00174-0
  21. Parke R, McGuinness S, Eccleston M. Nasal high-flow therapy delivers low level positive airway pressure. British Journal of Anaesthesia. 2009;103: 886–890. doi:10.1093/bja/aep280
  22. Lorent N, Vande Weygaerde Y, Claeys E, Guler Caamano Fajardo I, De Vos N, De Wever W, et al. Prospective longitudinal evaluation of hospitalised COVID-19 survivors 3 and 12 months after discharge. ERJ Open Research. 2022;8: 00004–2022. doi:10.1183/23120541.00004-2022
  23. Daher A, Cornelissen C, Hartmann NU, Balfanz P, Müller A, Bergs I, et al. Six months follow-up of patients with invasive mechanical ventilation due to COVID-19 related ARDS. International Journal of Environmental Research and Public Health. 2021;18: 5861. doi:10.3390/ijerph18115861
  24. Schoser B, Fong E, Geberhiwot T, Hughes D, Kissel JT, Madathil SC, et al. Maximum inspiratory pressure as a clinically meaningful trial endpoint for neuromuscular diseases: a comprehensive review of the literature. Orphanet Journal of Rare Diseases. 2017;12: 1–12. doi:10.1186/s13023-017-0598-0
  25. Romaszko-Wojtowicz A, Szalecki M, Olech K, Doboszyńska A. Assessment of the function of respiratory muscles in patients after COVID-19 infection and respiratory rehabilitation. Tropical Medicine and Infectious Disease. 2023;8: 57. doi:10.3390/tropicalmed8010057
  26. Walterspacher S, Schlager D, Walker DJ, Müller-Quernheim J, Windisch W, Kabitz HJ. Respiratory muscle function in interstitial lung disease. European Respiratory Journal. 2013;42: 211–219. doi:10.1183/09031936.00109512
  27. Surmachevska N, Tiwari V. Corticosteroid induced myopathy. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; January 2024 [cited 17th April 2023].
  28. Abodonya AM, Abdelbasset WK, Awad EA, Elalfy IE, Salem HA, Elsayed SH. Inspiratory muscle training for recovered COVID-19 patients after weaning from mechanical ventilation: a pilot control clinical study. Medicine (United States). 2021;100: 25339. doi:10.1097/MD.0000000000025339
  29. Fabbri L, Moss S, Khan FA, Chi W, Xia J, Robinson K, et al. Parenchymal lung abnormalities following hospitalisation for COVID-19 and viral pneumonitis: a systematic review and meta-analysis. Thorax. 2023;78: 191–201. doi:10.1136/thoraxjnl-2021-218275
  30. Han X, Fan Y, Alwalid O, Li N, Jia X, Yuan M, et al. Six-month follow-up chest CT findings after severe COVID-19 pneumonia. Radiology. 2021;299: E177–E186. doi:10.1148/radiol.2021203153
DOI: https://doi.org/10.2478/pneum-2025-0002 | Journal eISSN: 2247-059X | Journal ISSN: 2067-2993
Language: English
Page range: 8 - 16
Published on: Apr 16, 2025
In partnership with: Paradigm Publishing Services
Publication frequency: Volume open

© 2025 Sara Andreia Góis Morgado, Margarida V. Matias, Eva Brysch, Ana A. Santos, João Sousa Torres, Marta Rebelo, Eduarda Carmo, Fernando Nogueira, published by Romanian Society of Pneumology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.